Abstract | BACKGROUND: Patients with painful sensory neuropathy associated with Sjögren's syndrome-associated neuropathy often show severe neuropathic pain which is not relieved by conventional treatments. OBJECTIVE: PATIENTS AND METHODS: We examined 5 patients affected by painful sensory neuropathy associated with Sjögren's syndrome. All patients were treated with IVIg (0.4 g/kg/day for 5 days) and pain rating was assessed by the Visual Analogue Scale (VAS). RESULTS: All five patients showed a remarkable improvement in neuropathic pain following IVIg therapy. Pain, assessed by the determination of mean VAS score, was reduced by 73.4% from days 2-14 following treatment. The observed clinical improvement persisted for 2 to 6 months. One patient, examined by quantitative sensory testing (QST), showed an improvement of superficial sensory deficit accompanied by pain relief. CONCLUSION:
IVIg might be an effective treatment for pain in Sjögren's syndrome-associated neuropathy. Further studies should be done in a controlled, blind study.
|
Authors | Saori Morozumi, Yuichi Kawagashira, Masahiro Iijima, Haruki Koike, Naoki Hattori, Masahisa Katsuno, Fumiaki Tanaka, Gen Sobue |
Journal | Journal of the neurological sciences
(J Neurol Sci)
Vol. 279
Issue 1-2
Pg. 57-61
(Apr 15 2009)
ISSN: 1878-5883 [Electronic] Netherlands |
PMID | 19168191
(Publication Type: Journal Article)
|
Chemical References |
- Analgesics, Non-Narcotic
- Immunoglobulins, Intravenous
|
Topics |
- Aged
- Analgesics, Non-Narcotic
(therapeutic use)
- Disease Progression
- Female
- Humans
- Immunoglobulins, Intravenous
(therapeutic use)
- Male
- Median Nerve
(physiopathology)
- Middle Aged
- Neural Conduction
- Pain
(drug therapy, etiology)
- Pain Measurement
- Peripheral Nervous System Diseases
(complications, physiopathology)
- Sjogren's Syndrome
(physiopathology)
- Sural Nerve
(pathology, physiopathology)
- Tibial Nerve
(physiopathology)
- Treatment Outcome
|